Form 4 for RCEL AVITA Medical, Inc.
Accepted 2022-12-14 00:00:00 ET · period of report 2022-12-12 · accession 0001209191-22-061279 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-14 | 2022-12-12 | RCEL | COOK JEREMY CURNOCK | Dir | A - Grant | — | +12.6K | 16.9K | +289% | — |
| D | 2022-12-14 | 2022-12-12 | RCEL | COOK JEREMY CURNOCK | Dir | A - Grant | $0.00 | +5,395 | 5,395 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-12 | A | A | 12,589 | — | 16,939 | D | — | — | (F1) Represents an award of Restricted Stock Units ("RSUs"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest on the date 12 months following the grant date. (F2) Includes unvested RSUs. |
| 2 | Derivative | Stock Options (Right to Buy) | 2022-12-12 | A | A | 5,395 | $0.00 | 5,395 | D | $6.95 · — to 2032-12-12 | 5,395 Common Stock | (F3) These Stock Options vest on the date 12 months following the grant date. |